. . . . . . . "[Genetically amplified and expressed MDM2, often referred to as a 'hallmark' of DDLPS, mostly sustains a wild-type p53 genotype, substantiating the MDM2:p53 axis as a potential therapeutic target for DDLPS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:56+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .